Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting.

导出 LinkOut

翻译打印收藏纠错

作者： Giulio,Trapè ^[1] ; Gioia,De Angelis ^[1] ; Marco,Morucci ^[1] ; Michela,Tarnani ^[1] ; Cinzia,De Gregoris ^[1] ; Ambra,Di Veroli ^[1] ; Valentina,Panichi ^[2] ; Giuseppe,Topini ^[2] ; Loredana,Bassi ^[3] ; Raffaella,Isidori ^[3] ; Monica,Poscente ^[3] ; Vincenza,Innocenti ^[1] ; Elisa Emanueli,Cippitelli ^[1] ; Roberta,Talucci ^[1] ; Silvia,Bertelli ^[1] ; Alessandra,Crocicchia ^[1] ; Annalisa,Lippi ^[1] ; Giulia,Pezzuti ^[1] ; Michela,Fuschino ^[1] ; Raffaella,Randi ^[1] ; Cristina,Mastini ^[1] ; Silvia,Ciambella ^[1] ; Gloria,Pessina ^[3] ; Marco,Montanaro ^[1] ; Roberto,Latagliata ^[1]

作者单位： Hematology Unit-ASL Viterbo, Belcolle Hospital, Viterbo, Italy. ^[1] Laboratory of Immunophenotyping-ASL Viterbo, Belcolle Hospital, Viterbo, Italy. ^[2] Laboratory of Medical Genetics-ASL Viterbo, Ospedale Belcolle, Viterbo, Italy. ^[3]

关键词 acute myeloid leukemia high-risk myelodysplastic syndromes home care management hypomethylating agents

主题词人类(Humans);骨髓增生异常综合征(Myelodysplastic Syndromes);治疗结果(Treatment Outcome);回顾性研究(Retrospective Studies);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);医院(Hospitals);阿扎胞苷(Azacitidine)

DOI 10.1111/ejh.14012

PMID 37231885

发布时间 2023-07-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交